Showing posts with label Consumer Reports Health. Show all posts
Showing posts with label Consumer Reports Health. Show all posts

Friday, February 12, 2016

Cholesterol-Lowering Drugs May Be Linked to Diabetes


Consumer Reports Health / February 2016



You may have concerns about taking a cholesterol-lowering statin drug, such as atorvastatin (Lipitor and generic), rosuvastatin (Crestor), and simvastatin (Zocor and generic), after a recent study linked those drugs to an increased risk of type 2 diabetes. But Consumer Reports Best Buy Drugs experts say the heart-protective benefit of statins usually outweighs the risk of diabetes, so don’t skip a statin if you need one to lower your cholesterol.

Diabetes isn’t a new side effect of statins. The Food and Drug Administration added it to the label of all statins in 2012 based on a review of studies that found a slightly elevated risk. For example, one study that reviewed 13 randomized, controlled clinical trials of statins found that 4.9 percent of people who took one of the drugs for 4 years developed diabetes compared with 4.5 percent of those who didn’t take a statin.

Lower Cholesterol vs. Higher Blood Glucose

The new study, published in the Journal of General Internal Medicine, raises questions about whether the diabetes risk is higher than previously thought. Researchers looked at medical data of nearly 7,000 men and women with an average age of 53. About 31 percent of those who took a statin for an average of 5.5 years developed diabetes compared with 19 percent of those who didn’t.

But since the study was not a randomized, controlled study—the gold standard for determining whether a drug causes a particular side effect—it’s not known for sure that the increase in diabetes was entirely due to statins. The study participants might have had other factors that contributed to the development of diabetes.

"All we can say," says Ishak Mansi, M.D., an internist at the Veteran's Hospital in North Texas and co-author of the study, "[is] that in the healthy population selected ... the risk of diabetes after prolonged followup was higher than expected."

The risk of diabetes with statins is relatively low and is likely outweighed by the potential benefit of the medications to reduce LDL or “bad” cholesterol levels and prevent a heart attack or stroke, says Paul Thompson, M.D., chief of cardiology at Hartford Hospital in Connecticut. Previous research found that for every case of diabetes statins triggered, they prevented at least three heart attacks or other serious heart problems, Thompson adds.

“The bottom line is that the remote risk of developing type 2 diabetes should not deter you or influence your decision to use a statin if one is indicated,” says Marvin M. Lipman, M.D.,Consumer Reports’ chief medical adviser.

To figure out if a statin makes sense for you, our Best Buy Drug report on statins recommends using this calculator. It estimates your overall risk of a heart attack or stroke in the next 10 years based on your total cholesterol level, HDL “good” cholesterol, your age, blood pressure, and whether you smoke, or have diabetes.




Our medical advisers say that for some people with a low risk of heart attack or stroke—less than 10 percent over the next 10 years—diet and lifestyle changes should be the first step to lowering cholesterol. That includes adopting a healthy diet that is low in saturated fats, trans fats, and cholesterol, and making lifestyle changes such as exercising and losing weight if you need to or quitting smoking if you are a smoker.


Those changes could reduce your LDL and your heart attack and stroke risk low enough that you won’t need to take a statin. Or, if you already take a statin, these changes might allow you to discontinue your medication or lower your dose, which can in turn reduce your risk of side effects.

Our medical advisers also recommend that you use the calculator to look at how much taking a statin would reduce your risk. And talk with your doctor. You might find that reducing your cholesterol levels with a statin will not make much difference in your 10-year risk of heart attack or stroke. If that's the case, then skip it.


Consumer Reports has no relationship with any advertisers on this website. Copyright © 2006-2016 Consumers Union of U.S.


View gallery

Friday, October 2, 2015

12 Hospitals You Might Want to Avoid


They have high rates of MRSA, C. diff, 
and other dangerous infections

By Joel Keehn
Last updated: September 30, 2015

Every year, an estimated 648,000 people in the U.S. develop infections during a hospital stay, and about 75,000 die with one of those infections, according to the Centers for Disease Control and Prevention. That’s more than twice the number of people who die each year in car crashes.

To highlight the growing problem of dangerous hospital infections, Consumer Reports recently rated hospitals based on their infection rates for two of the most common and deadly bacterial infections in hospitals, MRSA and C. diff. And we identified the 12 hospitals in the country that earned low scores not only against those hospital infections but also three other infections in our Ratings. Those include infections following surgery as well as infections associated with urinary catheters and central-line catheters (large tubes that provide medicine and nutrition to patients).

Those 12 low-scoring hospitals performed poorly across all five types of hospital infections, based on data they provided to federal government agencies, between October 2013 and September 2014. "Getting a low score across all five infection categories is a red flag that the hospital is not focusing proper resources on infection control," says Doris Peter, Ph.D. director of the Consumer Reports Health Ratings Center.

Low-Scoring Hospitals for Infection Prevention
Here are the 12 low-scoring hospitals, listed alphabetically:

Brooklyn Hospital Center, Brooklyn, N.Y.
Decatur Memorial Hospital, Decatur, Ill.
Floyd Memorial Hospital and Health Services, New Albany, Ind.
Fremont-Rideout Health Group, Marysville, Calif.
Little Company of Mary Hospital and Health Care Centers., Evergreen Park, Ill.
Mercy St. Anne Hospital, Toledo, Ohio
Riverview Medical Center, Red Bank, N.J.
Rockdale Medical Center, Conyers, Ga.
St. Petersburg General Hospital, Saint Petersburg, Fla.
The Charlotte Hungerford Hospital, Torrington, Conn.
UF Health Jacksonville, Jacksonville, Fla.
Venice Regional Bayfront Health, Venice, Fla.

Note that the data our hospital Ratings are based on are released ​periodically throughout the year by the CDC. The CDC adjusts that data to account for factors such as the health of a hospital’s patients, its size, and whether it’s a teaching hospital. See our complete and the most current hospital Ratings as well as more about how we rate hospitals.

We’ve asked these hospitals what they are doing to improve, and why their infection rates were higher than average during the reporting time period of October 2013 to September 2014. To date, we have received written responses from the following hospitals:

Brooklyn Hospital Center
Floyd Memorial Hospital and Health Services
Fremont-Rideout Health Group
Little Company of Mary Hospital and Health Care Centers
Rockdale Medical Center
St. Petersburg General Hospital
UF Health Jacksonville
Venice Regional Bayfront Health

Decatur Memorial Hospital called us after we published our Ratings to discuss our findings but has not yet submitted a written response. We will add that response and any other as we receive them.

How Hospitals Can Improve
Our report, "How Your Hospital Can Make You Sick," revealed how hospitals and doctors contribute to hospital-acquired infections and antibiotic resistance and what hospitals and patients can do to protect against the problems.

Specifically, hospitals must do these things to prevent infections:
Follow infection control protocol, such as using protections including gowns, masks, and gloves by all staff.
Reduce overuse of antibiotics.
Have an antibiotic stewardship program. That should include mandatory reporting of antibiotic use to the CDC.
Accurately report how many infections patients get in the hospital.
Promptly report outbreaks to patients, as well as to state and federal health authorities.

Join our efforts to stop hospital infections and support our work in stopping the spread of antibiotic-resistant bacteria.

Friday, September 18, 2015

Does Excedrin Extra Strength Really Work in 15 minutes?

Today I am posting the new article from Consumer Reports because this one interests me personally. I use to live on Excedrin and monthly shots of Sumatriptan. Sumatriptan is produced and marketed by various drug manufacturers with many different trade names such as Imitrex, Imigran, and Treximet as a combination product with naproxen. I suffered for years with monthly migraines. Thankfully, I only experience migraines occasionally now.  I have no idea what the catalyst was but am so glad it happened! I still get a lot of headaches and Excedrin always helps alleviate the pain for me (takes a little longer than 15 minutes though). 

Does Excedrin Extra Strength Really Work in 15 minutes? 
We take a closer look at how fast you can expect relief from your headache  
By Steve Mitchell
September 13, 2015

When you’re suffering from a pounding headache, the quicker the pain fades the better. So a new television ad promising that Excedrin Extra Strength—a triple combination of acetaminophen, aspirin, and caffeine—can start to provide relief in just 15 minutes sounds promising. But you could be waiting a lot longer for relief—about two hours—according to the research we found.

Novartis, the manufacturer of Excedrin Extra Strength, said the claim in the ad was based on a proprietary study they refused to share with us.
We found just one relevant study of Excedrin Extra Strength published in the journal Headache in 2006. In that study, people with migraine headaches who took the drug didn’t experience any more pain relief after 15 minutes than those who took a placebo. In fact, people didn’t experience any more pain relief than the placebo group until 45 minutes had passed. They also didn’t rate the amount of pain reduction as meaningful until more than 2 hours had gone by—or about 8 times longer than the claim in the TV ad.
Bottom Line
Excedrin Extra Strength can help relieve headache pain, but it might take a couple of hours to kick in. Instead of paying more for the brand-name product though, we recommend considering a generic version, which contain the same active ingredients (250 milligrams of acetaminophen, 250 mg of aspirin, and 65 mg caffeine per tablet), but is usually less expensive.

Because Excedrin Extra Strength contains three different compounds, it poses several different risks. Its first ingredient, acetaminophen, can cause severe liver damage, so don’t take more than 8 tablets in 24 hours. And check any other medications you take to see if they contain acetaminophen to be sure you’re not taking too much. Consumer Reports medical advisers recommend taking no more than 3,250 mg of acetaminophen in a 24-hour period.

Aspirin can cause stomach bleeding, especially in people age 60 or older and those who have had stomach ulcers or take a blood thinning (anticoagulant) or steroid drug. And if you’re sensitive to caffeine, cut back on caffeinated beverages, such as coffee, tea, and sodas, to reduce the risk of nervousness, insomnia, and rapid heart beat.

If Excedrin Extra Strength doesn’t relieve your headache pain, talk to your doctor. You might have a migraine or another type of headache that requires a different medication.

For more on treating migraine headaches, check out our Best Buy Drugs report.

Editor's Note: These materials were made possible by a grant from the state Attorney General Consumer and Prescriber Education Grant Program, which is funded by a multistate settlement of consumer fraud claims regarding the marketing of the prescription drug Neurontin (gabapentin).

Friday, January 9, 2015

Recently published info regarding medications



Avoid these traps when paying for your medications

Americans spend a lot out of pocket on their medications—an average of $732 per year for those who regularly take a drug, according to the most recent CR Best Buy Drugs national poll. But new changes to Medicare and commercial drug coverage may make it tougher this year to get a good deal. 
Here are the biggest prescription drug traps we’ve found and how you can avoid them:



What over-the-counter drug labels really mean

Claims like ‘All Day,’ ‘Non-Drowsy,’ and ‘Maximum’ might not be what 


Thursday, October 30, 2014

Friends,

Consumer Reports Health has launched many new online "hubs" recently with focuses on a variety of Choosing Wisely related topics, including antibiotic overuse, medical tests before surgery, safe pregnancy, and screening tests. Today they launched a new hub on a topic that has been very present in the news recently -- that of caregiving, end-of-life decisions, and medical tests, and treatments for older adults.

Highlights of this hub include:
·  A short and emotional documentary that we created, called A Beautiful Death, which follows a courageous man through his final weeks of life -- including his funeral -- as he, his family, and his caregivers make end-of-life decisions together. 
·  A Consumer Reports magazine article, released to newsstands today, also called A Beautiful Death. A synopsis of the article is as follows: Paul Scheier lived a full and loving life. So when his cancer returned at age 86, he said no more hospitals, no chemo. He faced the end on his own terms—something that’s not easy to do in America today. But he showed that it can be done. 
·  A two-page report that we wrote, in conjunction with the National Hospice and Palliative Care Organization (NHPCO), called Palliative and Hospice Care: Comfort during a serious illness or the final months of life. You will also find a link toNHPCO's Moments of Life site on our hub.
·  Over 13 Choosing Wisely brochures on various topics for seniors, caregivers and those making end of life decisions. This includes a new six page "round-up" that we created on a variety of Choosing Wisely topics, called Advice for Caregivers: Treatments and tests for seniors. 
·  Links at the bottom of the hub to Consumer Reports magazines articles called Caring for the Caregiver, Regional Variation in Care, and Too Much Treatment. And, of course, we have a link to the Wikipedia article called "Caregiver."

As the national dialogue around caregiving and aging continues, I hope you find these materials useful and ask that you share them widely with your friends and family. 

CR will be Tweeting about these materials and today's launch, and invite you to join the conversation by following @ConsumerDavid. Below are some sample Tweets which you're welcome to use as you share this information on your own social media platforms:

For the Caregiving hub:
·  As the end approaches, what's the best care, and how do you get it? bit.ly/1tWC3eK #ChoosingWisely
·  #ChoosingWisely applies also to medical care toward the end of life. bit.ly/1tWC3eK
·  #ChoosingWisely when you're in charge of someone's care toward the end of their life. bit.ly/1tWC3eK

For the NHPCO guide:
·  This clear, new guide clarifies palliative care and hospice care.  bit.ly/1DxLjFl @NHPCO_news
·  A guide to providing comfort during serious illness or the final months. bit.ly/1DxLjFl @NHPCO_news

CRO End of Life package: 
·  A Beautiful Death: Consumer Reports' special feature on the end of life. bit.ly/1DQ488J
·  A life well-lived and thoughtfully ended: See Consumer Reports' feature on the end of life. bit.ly/1DQ488J

Anyone interested in reviewing Consumer Reports’ previously-released hubs, you can find them all here.